A research team at the University of Maryland's School of Medicine has recently unveiled an innovative artificial blood technology designed to effectively address the blood supply challenges faced in emergency healthcare. This artificial blood is created by extracting hemoglobin from real blood and encapsulating it in lipid foams to form red blood cells, which are then freeze-dried into a powder that can be stored at room temperature for years. First responders can simply add water to produce transfusable artificial blood in just one minute, which is crucial for immediate treatment of injuries at accident sites or on the battlefield. Each year, tens of thousands of people in the United States die from excessive blood loss, making effective countermeasures increasingly important.
One of the standout features of this technology is the artificial red blood cells created from hemoglobin extracted from expired blood. The innovative design of protective lipid bubbles not only shields the hemoglobin from toxic effects but also addresses the technical challenges faced in previous artificial blood studies. The research team has successfully freeze-dried these artificial red blood cells, allowing them to be stored at room temperature for several years, making them convenient for emergency use.
In a series of experiments involving rabbits, the research team simulated a severe blood loss scenario. The results showed that after the injection of artificial blood, the rabbits' physiological indicators, including heart rate and blood pressure, quickly rebounded, leading to a marked improvement in their health. Their mobility and behavior began to return to normal, and even the color of their eyes and ears became healthier, indicating an effective distribution of oxygen.
This artificial blood technology isn’t just for emergency medicine; military medics can also harness it to save injured soldiers. The U.S. Department of Defense has invested over $58 million in research projects, including ErythroMer synthetic blood, to develop components for coagulation and blood pressure maintenance. The Defense Advanced Research Projects Agency has noted that bleeding is a leading cause of preventable death on the battlefield, making the development of a reliable blood supply system an urgent priority.
Dr. Allan Doctor, who is leading the project, stated that the team has successfully replicated all the crucial functions of blood in emergency situations, making it effective from the moment of an accident. Although the results of experiments on rabbits have left researchers optimistic, it is still necessary to demonstrate its safety and efficacy for humans, with plans to begin human trials within the next two years.
Industry experts are taking a cautious stance on this new technology. While it presents an innovative solution, the research on artificial blood has faced many challenges over the years, and further verification through clinical trials is still needed. If it successfully advances to the clinical testing phase, this technology holds the potential to completely transform the treatment of patients experiencing blood loss outside of hospitals, and it could become a key breakthrough in emergency medical care.
This portable artificial blood powder boasts the advantage of long-term storage, providing significant medical convenience in remote areas, disaster locations, or military conflicts. In the coming years, clinical trials of similar technologies will offer new perspectives for addressing urgent medical issues.
Source: NPR
